Glaukos (GKOS) Return on Invested Capital (2016 - 2022)
Glaukos' (GKOS) quarterly Return on Invested Capital came in at 0.0% in Q1 2022, little changed year-on-year from 0.0% in Q1 2021, and up 50.33% on a QoQ basis from 0.0% in Q4 2021.
Glaukos (GKOS) Return on Invested Capital (2016 - 2022) Analysis & Trends
Glaukos (GKOS) has 4 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2022.
- On a quarterly basis, Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q1 2022; TTM through Mar 2022 was 0.0%, a 0.0% change from a year earlier, with the FY2015 full-year figure at 0.01%, changed N/A from the prior year.
- Return on Invested Capital for Q1 2022 stood at 0.0%, up from 0.0% in the prior quarter.
- Over the last five years, Return on Invested Capital for GKOS reached as high as 0.0% in Q1 2022 and fell as low as 0.0% in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.01% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.01% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.00% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.00% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 0.00% |